J.P. Morgan Life Sciences Private Capital names Bruce N. Rogers venture partner - JPM News | RalliesJ.P. Morgan Life Sciences Private Capital names Bruce N. Rogers venture partner
J
JPM• Bruce N. Rogers appointed venture partner
- JPMorgan appointed Bruce N. Rogers as venture partner at J.P. Morgan Life Sciences Private Capital.
- Rogers is president and CEO of a precision immunology portfolio company backed by the unit.
- He previously led Morphic Therapeutic, joining in 2016 as chief scientific officer, before its USD 3.2 billion sale to Eli Lilly in 2024.
- Rogers later served at Eli Lilly as senior vice president and CEO of Morphic, overseeing integration of the business.
- Earlier roles included head of neuro-opportunities at Pfizer, with 16 years in medicinal chemistry at Pfizer and Pharmacia.
•
